Corrigendum to “Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity” [Pharmacol. Rep. 66 (2014) 137–142]

Corrigendum to “Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity” [Pharmacol. Rep. 66 (2014) 137–142]

Pharmacological Reports 69 (2017) 587 Contents lists available at ScienceDirect Pharmacological Reports journal homepage: www.elsevier.com/locate/ph...

148KB Sizes 0 Downloads 15 Views

Pharmacological Reports 69 (2017) 587

Contents lists available at ScienceDirect

Pharmacological Reports journal homepage: www.elsevier.com/locate/pharep

Corrigendum

Corrigendum to “Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity” [Pharmacol. Rep. 66 (2014) 137–142]  ska, Anna Strze˛pa, Marian Szczepanik* _ n Monika Majewska-Szczepanik, Iwona Dorozy Department of Medical Biology, Jagiellonian University College of Medicine, Kraków, Poland

The authors wish to note an incorrectly listed financial support grant. The National Science Centre grants UMO-2012/05/B/NZ6/00997 and UMO-2011/03/B/NZ6/00821 were inadvertently listed. The authors regret this error. The correct Funding section read as follows: Funding This work was supported by grant from Ministry of Science and Higher Education N N401 545940 to Marian Szczepanik.

DOI of original article: http://dx.doi.org/10.1016/j.pharep.2013.06.008 * Corresponding author. E-mail address: [email protected] (M. Szczepanik). http://dx.doi.org/10.1016/j.pharep.2017.01.017 1734-1140/